SBIR-STTR Award

Development of a Novel Agent for Alcohol Dependence
Award last edited on: 10/23/03

Sponsored Program
SBIR
Awarding Agency
NIH : NIAAA
Total Award Amount
$115,007
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
H M Shepard

Company Information

Thiopharma Inc

1256 Quail Gardens Court
Encinitas, CA 92024
   N/A
   ozcitizen@aol.com
   N/A
Location: Single
Congr. District: 49
County: San Diego

Phase I

Contract Number: 1R43AA014566-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2003
Phase I Amount
$115,007
Studies are proposed to complete the development of S-methyl N, Ndiethylthiolcarbamate sulfoxide (DETC-MeSO), a novel agents for the treatment of alcohol dependence. Specifically the following studies will be performed. 1. Complete the process chemistry development for DETC-MeSO and its Isomers. (carried out at Thiopharma, Inc) 2. Synthesize sufficient scale UP quantities for preclinical toxicology studies. (carried out at Pharm-Eco Laboratories, Inc) 3. Carry out pharmacokinetic studies in rats to support preclinical toxicology studies. (carried out at The University of Kansas) 4. Preclinical toxicology studies in rats and dogs. (carried out at Battelle).

Thesaurus Terms:
alcoholism /alcohol abuse, alcoholism /alcohol abuse chemotherapy, drug addiction, drug design /synthesis /production, sulfoxide, thiocarbamate analytical method, disulfiram, method development, pharmacokinetics, toxicology electrospray ionization mass spectrometry, laboratory rat, matrix assisted laser desorption ionization

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----